Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

News Details

(15/04/2026 16:10)

Eris Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

As of March 2026, 53.92% is owned by Indian Promoters and 46.08% by Public.

Institutional holds 26.74% (Insurance Companies 1.31%) and Non-Institutional holds 19.33% as Public shareholders.

Top four Promoters holding highest number of shares of Eris Lifesciences company are Amit Indubhusan Bakshi (583.60 lakhs shares / 42.12%), Rajendrakumar Rambhai Patel (59.40 lakhs shares / 4.29%), Inderjeet Singh Negi (59.40 lakhs shares / 4.29%) and Kaushal Kamleshkumar Shah (44.69 lakhs shares / 3.23%).

Out of 747.09 lakhs shares, Promoters of Eris Lifesciences Company has over 126.41 lakhs (16.92%) shares on pledge as of March 31, 2026.
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
CDSL – MyEasi App App Store: https://apps.apple.com/in/app/cdsl-myeasi-app/id6737304195      Google Play Store: https://play.google.com/store/apps/details?id=com.cdsl.myeasi   |   NSDL – Speede App : App Store: https://apps.apple.com/in/app/nsdl-speede-app/id922834763      Google Play Store: https://play.google.com/store/apps/details?id=com.msf.NSDL.Android